International scientific society · Founded 2026
SIRiiM International Society for Radiation Medicine, Immunity and Immunomodulation

Home / PCP / LDRT

Tutorial 2

LDRT basics for primary care

Low-dose radiation therapy is not cancer therapy with the volume knob turned down. It is an attempt to modulate inflammation. That changes consent, follow-up and what “success” is allowed to mean.

The dose idea you need in one paragraph

Immunomodulatory effects of low-dose X-irradiation are not linear. Across several leukocyte and endothelial readouts the signal peaks around 0.3–0.7 Gy and falls off on either side. Cancer radiotherapy uses tens of grays. Mixing those sentences in a patient conversation is how this field gets misunderstood. Read the Society page on immunity before teaching this to a trainee.

What “a course” usually looks like in arthritis teaching

  • Brief sessions. A handful of short, painless visits rather than a multi-week cancer course.
  • Gentle dose. Low fraction size, limited total dose, local fields.
  • Gradual relief. Improvement, when it happens, is often measured in weeks, not hours.

Details belong to the treating radiation oncologist and the guideline in force. See arthritis.

Risk arithmetic you should not skip

Benign disease means benign-disease follow-up. A patient irradiated at 40 may have fifty years in which a second malignancy can appear. Trials that stop at twelve months cannot see the harm they are meant to exclude. Younger patients raise the bar; they do not lower it.

COVID, again. Encouraging single-arm pneumonia series did not survive a randomised, sham-controlled trial in ventilated patients. Uncontrolled inflammatory endpoints will flatter you. Design against that, or do not open the indication.

Next

Immunity for the referring clinician · Partner training

Informational Society education, not medical advice.